Tauriga Sciences Inc (TAUG)
0.00
USD |
OTCM |
May 07, 16:00
Tauriga Sciences Revenue (TTM): 0.3135M for Dec. 31, 2021
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2021 | 0.3135M |
September 30, 2021 | 0.2859M |
June 30, 2021 | 0.2539M |
March 31, 2021 | 0.2853M |
December 31, 2020 | 0.2476M |
September 30, 2020 | 0.2605M |
June 30, 2020 | 0.2548M |
March 31, 2020 | 0.2344M |
December 31, 2019 | 0.259M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 |
Date | Value |
---|---|
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 | |
December 31, 2010 | |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 | |
December 31, 2009 | |
September 30, 2009 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.2344M
Minimum
Mar 2020
0.3135M
Maximum
Dec 2021
0.2661M
Average
0.259M
Median
Dec 2019
Revenue (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 7.098M |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |